500 patients67,039 observations150 daysLIVE

Patient P-03280

Synthetic patientONX-7 · Day 145 · 65–74 · M · baseline S13Open companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
70%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S13
  2. Day 75 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 75.

Primary contributors, last 14 days
  • Toxicity+12
  • Inflammatory activity+10
  • GI instability+8
  • Nutritional resilience-4
  • Treatment adherence-2

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    67%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 83% showed improvement
    • median effect visible after 8 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 55
      • MicrobiomeButyrate capacity 38/100
      • Daily logFibre intake low in recent food logs
    • Mucosal barrier integrity 50
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 67 and rising
    • Autonomic recovery 45
      • WearableResting HR 78 bpm
      • Wearable1,825 steps/day
    • Inflammatory signalling 40
      • BloodInflammatory load index 62
      • WearableHRV 30 ms, trending down
    • Drug metabolism and exposure 20
      • BloodToxicity index 50
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2 · butyrate capacity 38/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    35 ms
    Sleep
    6.8 h
    Steps
    779
    Resting HR
    79 bpm
    Daily log: GI score 67, nutritional resilience 37, adherence 65.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0318349%S0354
    P-0309947%S17CR-01improved55
    P-0344447%S1762
    P-0335245%S1959
    P-0322544%S19GI-04improved50
    P-0300443%S0356
    P-0308043%S0962
    P-0319143%S19GI-04improved51
    P-0316642%S20CR-01improved62
    P-0338441%S0155
    P-0345141%S0862
    P-0303140%S16CR-01improved49